Antipsychotic News and Research

RSS

Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.

Cannabinoid medicines have enormous therapeutic potential but reliable studies still lacking

For more than twenty years now, international research into the endocannabinoid system in the human body has been seeking to understand the mode of action of cannabis and its constituents.

18 Dec 2021

Antipsychotic drugs associated with increase in risk of breast cancer

Researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed antipsychotic medications are associated with a significant increase in risk of breast cancer.

6 Dec 2021

Study uncovers a promising drug candidate to minimize dyskinesia in Parkinson's patients

A new study from Texas Biomedical Research Institute (Texas Biomed) and collaborators has identified a promising drug candidate to minimize uncontrolled, erratic muscle movements, called dyskinesia, associated with Parkinson's disease.

1 Dec 2021

COVID-19 and subacute neuropsychiatric symptoms in adolescents

A new paper discusses neurologic symptoms in children with COVID-19.

27 Oct 2021

Study maps hotspots of low-value care use at individual health systems

Researchers estimate that up to $101 billion in health care spending is wasted each year due to over-treatment or the delivery of "low-value care." Low-value care includes a wide array of tests and treatments that are medically unnecessary and for which the potential for harm outweigh the potential for benefit. While researchers have charted the ongoing use of low-value care on national and regional levels, little research exists on how health systems across the country use low-value care and how they compare to each other.

28 Sep 2021

Long-term injectables plus counseling improve medication adherence in bipolar disorder patients

Researchers have found that adherence to taking medications improved in people with bipolar disorder with the use of long-term injectable meds combined with psychosocial intervention.

17 Sep 2021

NPS MedicineWise encourages people with dementia to take an active role in decisions about care

The Royal Commission into Aged Care Quality and Safety revealed shocking stories of the use of ‘chemical restraints’ in residential aged care and highlighted the need for reform across the sector.

1 Sep 2021

Playlist for Life’s new campaign highlights how personal playlists can help people with dementia

Music that gives you that flashback feeling can be a lifeline if you are affected by dementia. Playlist for Life’s ‘Songs for Dementia’ campaign focuses on how personally meaningful music can help the person with dementia to shine through. Put simply, music has the power to shine a spotlight on the ‘me’ in dementia.

1 Sep 2021

Better communication and patient-centered psychiatric care are key to reducing absconding events

Patients run away from in-patient mental health facilities because they experience bad news or conflict, or because they have specific everyday things to do, a Flinders University study has found, adding fewer than 2 in every 100 patients leave care.

26 Aug 2021

Innovative strategy for early diagnosis of schizophrenia

An innovative strategy that analyzes a region of the genome offers the possibility of early diagnosis of schizophrenia, reports a team led by researchers at Baylor College of Medicine.

3 Aug 2021

Investigational antipsychotic treatment offers sustained benefits for people with dementia-related psychosis

Evidence of the sustained benefits of an investigational antipsychotic treatment for people with dementia-related psychosis has been published.

22 Jul 2021

Psychiatric patients have higher odds of hospitalization and death following COVID-19

In the largest systematic review and meta-analysis to date on COVID-19 outcomes in individuals with psychiatric disorders, the odds of dying or being hospitalized following COVID-19 infection were determined to be twice as high in comparison to persons without mental disorders.

16 Jul 2021

22 blood plasma lipids found to be associated with lower symptom improvement in schizophrenia

Researchers from Skoltech and the Mental Health Research Center have found 22 lipids in the blood plasma of people with schizophrenia that were associated with lower symptom improvement over time during treatment.

6 Jul 2021

New AI software shows promise to prevent relapse of severe mental illness

New AI software developed by researchers at Flinders University shows promise for enabling timely support ahead of relapse in patients with severe mental illness.

15 Jun 2021

Adults with schizophrenia have increased risk of dying from suicide

Adults with schizophrenia have an elevated risk of dying from suicide. Yet there's only limited understanding of when and why people with schizophrenia die of suicide --in part because research studies have looked at relatively small groups of patients.

27 May 2021

Scientists use anti-psychotics to treat flies displaying behavioral problems linked to schizophrenia-associated genes

Scientists have successfully treated flies displaying behavioral problems linked to newly discovered schizophrenia-associated genes in humans, using common anti-psychotics.

20 May 2021

Scientists identify molecular mechanism behind weight gain in patients taking antipsychotics

Scientists with UT Southwestern's Peter O'Donnell Jr. Brain Institute have identified the molecular mechanism that can cause weight gain for those using a common antipsychotic medication.

12 May 2021

Linkam FDCS196 stage used in research to develop a novel transdermal delivery system for risperidone

The first study of its kind reports on the enhancement of skin permeability of risperidone (RIS) using eutectic systems.

From Linkam Scientific Instruments 14 Apr 2021

Antipsychotics could have a protective impact against SARS-CoV-2

Two studies led by the Mental Health Unit of the Virgen del Rocio University Hospital and involving researchers from the US conclude that antipsychotic drugs could have a protective effect against SARS-CoV-2. For this reason, patients treated with these drugs have a lower risk of becoming infected or suffer a milder form of the disease if they do become infected.

9 Apr 2021

Insomnia linked to more suicidal thoughts and disease severity in schizophrenia patients

Insomnia is a common problem in patients with schizophrenia, and a new study reinforces a close association between insomnia, more suicidal thoughts and actions and increased problems like anxiety and depression in these patients.

6 Apr 2021